Committee Composition

Chair of the Board = Chair of the Board Committee Chair = Chair Committee Member = Member
  Audit Compensation Nominating and Governance
Donnelly, Howard Chairman of the Board      
Clemmer, James C.      
Auen, Eileen   Member of Compensation Committee  
Gold, Jeffrey Member of Audit Committee   Member of Nominating and Governance Committee

Jeffrey G. Gold has served as Director since 1997. Mr. Gold is a Venture Partner for Longitude Capital, a healthcare venture capital fund. Mr. Gold was President and Chief Executive Officer of CryoVascular Systems, a peripheral vascular disease device company, from 2001 through its sale to Boston Scientific in 2005. From 1997 to 2001 he was Executive Vice President and Chief Operating Officer of CardioThoracic Systems Inc., a company engaged in the development and introduction of devices for beating-heart coronary bypass surgery. Before that, Mr. Gold spent 18 years with Cordis Corporation in a variety of senior management roles, including Vice President of Manufacturing and Vice President of Research and Development, and was a co-founder and President of Cordis Endovascular Systems, a Cordis subsidiary engaged in the interventional neuroradiology business. At Cordis, Mr. Gold also had responsibility for the peripheral vascular business. He serves on the board of directors of several start-up medical device companies and is a member of the Executive Committee for the Center for Entrepreneurship and Innovation at the University of Florida, as well as the Commercialization Advisory Board for the Cleveland Clinic.

Gould, Kevin   Committee Chair for Compensation Committee  
Johnson, Wesley Member of Audit Committee   Committee Chair for Nominating and Governance Committee
LaPorte, Steve   Member of Compensation Committee Member of Nominating and Governance Committee
Meteny, Dennis Committee Chair for Audit Committee    
Reed, Jan Member of Audit Committee    
  • Stock Information
  • Ticker ANGO
    Exchange NASDAQ
    Price $16.54
    Change - 0.07
    Volume 229,139
    Mar 23, 2018 - 4:00 PM ET
  • Search Investor Relations